483 Roundup: FDA Targets Seven Devicemakers for Noncompliance

The GMP Letter
A A
The FDA flagged device firms in the U.S., France, Germany, the United Kingdom, the Czech republic, and India for a range of issues, including MDR reports, CAPA failures and other GMP issues.

To View This Article:

Login

Subscribe To The GMP Letter